Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$718M |
| 2 |
Microsoft
MSFT
|
+$662M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$404M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$342M |
| 5 |
NVIDIA
NVDA
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$713M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$709M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$626M |
| 5 |
Home Depot
HD
|
+$561M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.54% |
| 2 | Healthcare | 5.02% |
| 3 | Consumer Discretionary | 4.7% |
| 4 | Financials | 4.22% |
| 5 | Communication Services | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
United Parks & Resorts
PRKS
$2.1B
| $2.49M | ﹤0.01% |
44,395
+11,133
| +33% | +$628K |
|
1977
CALL
Pultegroup
PHM
$24.1B
| $2.49M | ﹤0.01% |
+32,000
| New | +$2.17M |
|
1978
CALL
Coty
COTY
$2.42B
| $2.48M | ﹤0.01% |
+202,100
| New | +$2.39M |
|
1979
BioCryst Pharmaceuticals
BCRX
$2.28B
| $2.48M | ﹤0.01% |
352,543
-306,924
| -47% | -$2.46M |
|
1980
Green Brick Partners
GRBK
$3.04B
| $2.47M | ﹤0.01% |
43,468
+12,003
| +38% | +$559K |
|
1981
Genpact
G
$5.96B
| $2.47M | ﹤0.01% |
65,672
+9,520
| +17% | +$383K |
|
1982
CALL
Constellation Brands
STZ
$22.2B
| $2.46M | ﹤0.01% |
10,000
| – | – |
|
1983
Global E Online
GLBE
$6.6B
| $2.46M | ﹤0.01% |
59,967
+50,553
| +537% | +$1.66M |
|
1984
Customers Bancorp
CUBI
$2.66B
| $2.45M | ﹤0.01% |
81,013
+60,773
| +300% | +$1.36M |
|
1985
Arcus Biosciences
RCUS
$3.55B
| $2.45M | ﹤0.01% |
120,646
-231,290
| -66% | -$4.4M |
|
1986
ESCO Technologies
ESE
$8.17B
| $2.45M | ﹤0.01% |
23,624
+7,107
| +43% | +$683K |
|
|
MRTX
1987
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.45M | ﹤0.01% |
67,704
-91,289
| -57% | -$3.76M |
|
1988
Invivyd
IVVD
$158M
| $2.44M | ﹤0.01% |
2,327,146
+2,325,904
| +187,271% | +$2.97M |
|
1989
Syndax Pharmaceuticals
SNDX
$1.69B
| $2.44M | ﹤0.01% |
116,712
-443,703
| -79% | -$9.24M |
|
1990
CALL
PTC Therapeutics
PTCT
$5.68B
| $2.44M | ﹤0.01% |
60,000
+30,200
| +101% | +$1.48M |
|
|
1991
PUT
PTC Therapeutics
PTCT
$5.68B
| $2.44M | ﹤0.01% |
60,000
+30,200
| +101% | +$1.48M |
|
1992
InterDigital
IDCC
$7.87B
| $2.44M | ﹤0.01% |
25,236
+7,667
| +44% | +$621K |
|
1993
GXO Logistics
GXO
$5.77B
| $2.44M | ﹤0.01% |
38,775
-2,473
| -6% | -$139K |
|
1994
Parsons
PSN
$4.72B
| $2.44M | ﹤0.01% |
50,588
-7,800
| -13% | -$356K |
|
1995
PUT
Booking.com
BKNG
$149B
| $2.43M | ﹤0.01% |
+22,500
| New | +$2.38M |
|
1996
iShares Russell 2000 Value ETF
IWN
$14.3B
| $2.42M | ﹤0.01% |
17,160
-125,595
| -88% | -$17M |
|
1997
Veracyte
VCYT
$3.7B
| $2.41M | ﹤0.01% |
94,650
-144,514
| -60% | -$3.5M |
|
1998
Zentalis Pharmaceuticals
ZNTL
$337M
| $2.41M | ﹤0.01% |
85,407
-103,312
| -55% | -$2.48M |
|
1999
CALL
CME Group
CME
$96.3B
| $2.41M | ﹤0.01% |
13,000
+4,000
| +44% | +$739K |
|
2000
Array Technologies
ARRY
$803M
| $2.41M | ﹤0.01% |
106,555
-508,668
| -83% | -$10.9M |
|
Similar funds
Citigroup's Q2 2023 Portfolio in Review
As of Q2 2023, Citigroup held 5,906 positions worth $153B, up 6.9% from $143B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citigroup's Q2 2023 filing shows 463 new, 2,756 increased, 1,590 reduced and 354 closed positions. Its largest new stake was Vesta Real Estate: 3,353,619 shares worth $108M. The largest sale was iShares Russell 2000 ETF, an estimated $713M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citigroup's largest Q2 2023 buy was Vesta Real Estate: 3,353,619 shares worth $108M.
- Citigroup added most to Vanguard Morningstar Total Stock Market ETF in Q2 2023, an estimated $718M increase.
- Citigroup's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $713M.
- Citigroup fully exited DCP Midstream, LP in Q2 2023, selling an estimated $198M.
- Citigroup's ten largest holdings make up 34% of its $153B portfolio in Q2 2023.
- Citigroup opened 463 new positions and closed 354 in Q2 2023.
- Citigroup's portfolio value rose 6.9% quarter-over-quarter to $153B.
Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.